Literature DB >> 26512192

Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib.

Min Kyung Lee1, Won Joo Kwon1, Eun Byul Cho1, Eun Joo Park1, Kwang Ho Kim1, Kwang Joong Kim1.   

Abstract

Entities:  

Year:  2015        PMID： 26512192      PMCID： PMC4622912          DOI： 10.5021/ad.2015.27.5.641

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  5 in total

1.  Cutaneous reactions to STI571.

Authors:  M Brouard; J H Saurat
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

2.  Immunohistochemical characterization of cutaneous drug eruptions by STI571.

Authors:  Hyun Jeong Park; Hei Sung Kim; Hee Jung Kim; Jun Young Lee; Baik Kee Cho; Ah Won Lee; Do Young Yoon; Dae Ho Cho
Journal:  J Dermatol Sci       Date:  2005-04       Impact factor: 4.563

3.  Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients.

Authors:  Laurence Valeyrie; Sylvie Bastuji-Garin; Jean Revuz; Nicolas Bachot; Janine Wechsler; Patrice Berthaud; Michel Tulliez; Stéphane Giraudier
Journal:  J Am Acad Dermatol       Date:  2003-02       Impact factor: 11.527

4.  Stevens-Johnson syndrome after treatment with STI571: a case report.

Authors:  Liang-Tsai Hsiao; Hung-Ming Chung; Jen-Tsun Lin; Tzeon-Jye Chiou; Jin-Hwang Liu; Frank S Fan; Wei-Shu Wang; Chueh-Chuan Yen; Po-Min Chen
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998

5.  Lichenoid drug eruption after low-dose imatinib mesylate treatment.

Authors:  Jae-Hyung Lee; Jong-Yoon Chung; Mi-Young Jung; Cho Rok Kim; Ji-Ho Park; Ji-Hye Park; Jong-Hee Lee; Joo-Heung Lee; Jun-Mo Yang; Dong-Youn Lee
Journal:  Ann Dermatol       Date:  2013-11-30       Impact factor: 1.444
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.